NewsRx

Search our medical news database

LabCorp

LabCorp to be the First National Commercial Lab to Offer Roche's COBAS TaqMan HBV Test

Published in Hepatitis Weekly, November 24th, 2008

Laboratory Corporation of America(R) Holdings (LabCorp(R)) (NYSE: LH) announces that it will be the first national clinical laboratory to offer HBV PCR testing using a newly FDA approved assay, the Roche COBAS(R) TaqMan(R) HBV Test. This assay, to be offered next week, is intended to be used as an aid in managing patients with chronic HBV infection undergoing antiviral therapy. Since the goal of HBV therapy is to treat until circulating virus can no longer be detected it is important that viral DNA monitoring assays provide a high level of sensitivity. The Roche COBAS(R) TaqMan(R) HBV Test accurately measures HBV DNA levels as low as 29 international units (IU) per mL, and can detect as...

Want to see the full article?

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Buy Now


Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of Hepatitis Weekly


NewsRx is Social

Follow us on your favorite social network by clicking on a button below:

Follow NewsRx on Twitter

NewsRx on Facebook

Awards

eHealthcare Leadership 2011 Winner
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

  • Google 2010 PageRank: #2 Among Top Health News and Media Publications
  • Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
  • Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
  • Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx on Facebook